. 2006 Apr 10;103(16):6338–6343. doi: 10.1073/pnas.0508143103

Table 1.

Clinical course of recipient mice after transplantation

Characteristic	C/EBPα^pos + bcr/abl	C/EBPα^−/− + bcr/abl
Survival, days (median)^*	22–169 (26)	20–157 (26)
Spleen weight, mg (median)^*	330–750 (517)	100–1000 (465)
WBC per μl (median)^*	18,000–230,000 (82,000)	7,300–71,000 (24,500)
Hemoglobin, g/dl (median)^*	11–14.8 (13.2)	10.2–18.5 (16.6)
Blasts^†	0.4 ± 0.4	8.6 ± 3.8^§
Myelocytes^†^‡	2.5 ± 0.7	0.3 ± 0.5^§
Neutrophils^†	64.7 ± 16.2	4.8 ± 5.7^§
Eosinophils^†	0.7 ± 0.7	0.0 ± 0.0
Lymphocytes^†	26 ± 16.2	17 ± 21.5
Monocytes^†	4.2 ± 1.6	1.6 ± 0.9^§
Normoblasts, erythroblasts^†	1.4 ± 1.5	66.5 ± 31.4^§

More than 80% of the mice were killed within 60 days after transplantation. The mouse with acute lymphocytic leukemia (recipient of C/EBPα^+/− + bcr/abl) is not included. For the differential counts, the percentage of each type of the nucleated blood cells ± SD is given.

*n = 7 for C/EBPα^pos and n = 9 for C/EBPα^−/− transplants.

^†n = 4 for C/EBPα^pos and n = 5 for C/EBPα^−/− transplants.

^‡Myelocytes include promyelocytes, myelocytes, and metamyelocytes.

^§P < 0.05.